Physician profile
Jaber Alanzi
NPI 1073748257
$5,222.48
in general payments reported to CMS, 2019-2025
39 companies · $2,013 in 2025
The $2,013 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $248 · 2021: $280 · 2022: $592 · 2023: $635 · 2024: $859 · 2025: $2,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,329 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,328.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Education | $178.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avyxa Pharma, LLC | $1,000.00 | 2025 | |
| Astellas Pharma US INC | $931.53 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $571.09 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $555.39 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $289.80 | 2019-2025 | Ams 700 |
| Olympus America INC. | $243.39 | 2022-2025 | Itind System, Soltive |
| Procept Biorobotics Corporation | $139.41 | 2021-2023 | Aquabeam Robotic System |
| Medtronic, INC. | $131.13 | 2022-2025 | Interstim |
| Tolmar, INC. | $120.58 | 2024-2025 | Eligard, Jatenzo, Rubraca |
| Urogen Pharma, INC. | $113.79 | 2022-2025 | Jelmyto |
| Antares Pharma, INC. | $89.85 | 2024 | Xyosted |
| Bayer Healthcare Pharmaceuticals INC. | $88.18 | 2019-2025 | |
| Myovant Sciences INC. | $86.43 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $67.45 | 2024 | Provenge |
| Endo Pharmaceuticals INC. | $62.29 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $59.73 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Axonics, INC. | $56.44 | 2023 | Axonics |
| Blue Earth Diagnostics | $54.47 | 2025 | Posluma |
| Immunitybio, INC. | $51.47 | 2025 | |
| Pfizer INC. | $48.40 | 2019-2024 | |
| Coloplast Corp | $38.92 | 2019-2023 | Speedicath |
| Dornier Medtech America, INC | $38.65 | 2022 | |
| Endo USA, INC. | $34.79 | 2025 | Xiaflex |
| Valencia Technologies Corporation | $33.48 | 2023-2024 | Ecoin Device Kit |
| Allergan, INC. | $33.28 | 2019 | |
| Progenics Pharmaceuticals, INC. | $32.16 | 2024 | |
| Convatec INC. | $29.90 | 2024 | |
| Teleflex LLC | $26.14 | 2025 | Urolift |
| Kowa Pharmaceuticals America, INC. | $23.21 | 2022 | |
| Bluewind Medical | $21.35 | 2024 | Revi |
| Foundation Medicine, INC. | $21.31 | 2023 | Foundationone Cdx |
| Pharmaand Gmbh | $19.60 | 2025 | Rubraca |
| Verity Pharmaceuticals INC. | $18.89 | 2025 | Trelstar |
| C. R. Bard, INC. & Subsidiaries | $18.21 | 2021 | |
| Abbvie INC. | $17.73 | 2025 | |
| Telix Pharmaceuticals | $14.68 | 2025 | Illuccix |
| Astrazeneca Pharmaceuticals Lp | $14.34 | 2025 | Lynparza |
| Merck Sharp & Dohme LLC | $13.72 | 2025 | Keytruda Qlex, Keytruda |
| Ferring Pharmaceuticals INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaber Alanzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.